Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Healthequity Inc shares valued at $97,846 were purchased by Delano Ladd on Jul 03 ’25. At $100.87 per share, Delano Ladd acquired 970 shares.
Also, James M. Lucania purchased 2,375 shares, netting a total of over 239,571 in proceeds.
Before that, Stephen Neeleman had added 1,049 shares to its account. In a trade valued at $105,815, the Officer bought Healthequity Inc shares for $100.87 each.
Analysts at Raymond James upgraded the stock from ‘”an Outperform”‘ to ‘”a Strong buy”‘ outlook in a report released in late March. As of December 04, 2024, Mizuho has initiated its “an Outperform” rating for HQY. Earlier on November 15, 2024, Goldman initiated its rating. Their recommendation was “a Neutral” for HQY stock.
Analyzing HQY Stock Performance
On last trading session,, Healthequity Inc [NASDAQ: HQY] rose 3.16% to $98.8. The stock’s lowest price that day was $95.62, but it reached a high of $99.47 in the same session. During the last five days, there has been a surge of approximately 1.95%. Over the course of the year, Healthequity Inc shares have jumped approximately 22.01%.
Support And Resistance Levels for Healthequity Inc (HQY)
RSI (Relative Strength Index) is 50.50 on the 14-day chart, showing neutral technical sentiment.
Is Healthequity Inc subject to short interest?
Stocks of Healthequity Inc saw a sharp rise in short interest on 2025-07-15 jumping by 0.17 million shares to 5.43 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 5.26 million shares. A jump of 3.13% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.17 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.17.
Which companies own the most shares of Healthequity Inc (HQY)?
In terms of Healthequity Inc share price expectations, FactSet research, analysts set an average price target of 112.5 in the next 12 months, up nearly 17.47% from the previous closing price of $95.77. Analysts anticipate Healthequity Inc stock to reach 115 by 2025, with the lowest price target being 110. In spite of this, 11 analysts ranked Healthequity Inc stock as Buy at the end of 2025. On April 04, 2024, JMP Securities assigned a price target of “a Mkt outperform” to the stock and initiated coverage with a $101.
